← SynDRA
Didox
SynDRA canonical compound SYN1951632 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | RRM1 |
| Mechanism of action | ribonucleotide reductase inhibitor |
| Indication | breast cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- ribonucleotide reductase inhibitor
Cross-references
Synonyms
- N,3,4-Trihydroxybenzamide
- 3,4-Dihydroxybenzohydroxamic acid
- NSC 324360
- Benzamide, N,3,4-trihydroxy-
- 3,4-Dihydroxyphenylhydroxamic acid
- UNII-L106XFV0RQ
- VF 147
- DIDO
- CCRIS 7909
- BRN 2096682
- L106XFV0RQ
- C7H7NO4
- NSC324360
- AC1L1F1T
- Benzamide,3,4-trihydroxy-
- AC1Q5DI9
- N-3,4-Tridhydroxybenzamide
- SCHEMBL171446
- CHEMBL367788
- SCHEMBL18732059
- Didox, >
- SCHEMBL18346609
- CTK8F9165
- DTXSID90220134
- QJMCKEPOKRERLN-UHFFFAOYSA-N
- MolPort-009-019-216
- KS-00001DF2
- BCP16846
- ZINC3872288
- 1716AH
Look up Didox in the interactive SynDRA portal →